Protagenic Therapeutics, Inc. PTIX
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.46M | 1.37M | -5.55M | -- | -- |
| Total Depreciation and Amortization | 45.00K | 49.30K | 37.80K | -- | -- |
| Total Amortization of Deferred Charges | 1.32M | 1.57M | 423.40K | -- | -- |
| Total Other Non-Cash Items | -10.04M | -7.52M | 364.90K | -- | -- |
| Change in Net Operating Assets | 629.70K | 1.15M | 217.40K | -- | -- |
| Cash from Operations | -2.58M | -3.39M | -4.51M | -- | -- |
| Capital Expenditure | -3.30K | -3.30K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -310.00K | 633.20K | 943.20K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1.28M | -- | -- |
| Cash from Investing | -313.30K | 629.90K | 2.22M | -- | -- |
| Total Debt Issued | -15.40K | 646.20K | 252.10K | -- | -- |
| Total Debt Repaid | -533.90K | -533.90K | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 4.35M | 4.35M | -- | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -549.30K | 4.46M | 4.60M | -- | -- |
| Foreign Exchange rate Adjustments | -83.70K | -202.00K | -180.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.53M | 1.49M | 2.13M | -- | -- |